Skip to content
Screener

ResMed Inc. RMD Total Revenue

Discontinued — last reported Q4 '26

Total Revenue at other companies

Inogen logo
InogenINGN
$95.08M+3.0%
Five Point Holdings, Inc. logo
Five Point Holdings, Inc.FPH
$13.9M+86.0%
Inspire Medical Systems logo
Inspire Medical SystemsINSP
$204.58M+1.6%
Viemed Healthcare, Inc. logo
Viemed Healthcare, Inc.VMD
$75.41M+27.5%
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
$5.3B+5.8%
AdaptHealth logo
AdaptHealthAHCO
$819.8M+5.4%

Segments

By product

See full
Devices$1.47B+8.8%
Sleep and Breathing Health$1.29B+9.4%
Masks and other$1.05B+15.5%
Residential Care Software$171.92M+2.9%

By geography

See full
Global revenue$1.43B+10.8%
U.S., Canada and Latin America$818.67M+9.3%
Combined Europe, Asia and other markets$441.84M+15.9%

By segment

See full
Sleep and Breathing Health$1.29B+9.4%
Residential Care Software$171.92M+2.9%

Other financials

Income statement

See full
Gross profit$861.2M+5.0%
Operating income$448.7M-1.3%
Net income$383.4M+1.0%
EPS (diluted)$2.64+2.3%

Balance sheet

See full
Cash & equivalents$1.5B+21.5%
Total debt$825.9M-4.2%
Total equity$6.6B+10.3%
Total assets$9.0B+9.7%

Cash flow

See full
Operating cash flow$454.6M-15.6%
CapEx$51.1M+67.2%
Free cash flow$403.5M-20.6%

Valuation

See full
Market cap$34B-17.6%
Enterprise value$33.36B-18.5%
P/E22.3×-7.2×
P/S6×-2.0×

Profitability

See full
Gross margin61.1%+1.7pp
Operating margin33.4%+0.6pp
Net margin26.9%-0.3pp
FCF margin29.2%-3.1pp

Returns & leverage

See full
Return on equity24.3%-1.6pp
Debt / equity0.1×0.0×
Current ratio3.1×-0.3×

Where this comes from

Reported directly by ResMed Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: ResMed Inc.’s 10-K, filed August 13, 2026.

Filed
Aug 13, 2026, 5:17 PM EDT
Fiscal year
FY2026
Accession
0000943819-26-000047
Line itemJune 30, 2026June 30, 2025June 30, 2024
Net revenue - Sleep and Breathing Health products$4,977,630$4,504,890$4,101,172
Net revenue - Residential Care Software675,813641,437584,125
Net revenue5,653,4435,146,3274,685,297
Cost of sales - Sleep and Breathing Health products1,962,6071,864,1981,806,845
Cost of sales - Residential Care Software207,318195,043190,186
Cost of sales (exclusive of amortization shown separately below)2,169,9252,059,2411,997,031
Amortization of acquired intangible assets - Sleep and Breathing Health products6,2666,6465,515
Amortization of acquired intangible assets - Residential Care Software25,51325,47027,448

ITEM 8 CONSOLIDATED FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

FAQ

What is ResMed Inc.'s total revenue?
ResMed Inc. (RMD) reported total revenue of $1.46B in Q2 2026.
How has ResMed Inc.'s total revenue changed year-over-year?
ResMed Inc.'s total revenue increased by 8.6% year-over-year, from $1.35B to $1.46B.
What is the long-term trend for ResMed Inc.'s total revenue?
Over 4 years (2022 to 2026), ResMed Inc.'s total revenue has grown at a 12.1% compound annual growth rate (CAGR), from $3.58B to $5.65B.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about ResMed Inc.'s total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude